We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Independent Bank
INDB
$4.05B
| $380K | ﹤0.01% |
4,556
+567
| +14% | +$46.3K |
|
1502
First Trust Europe AlphaDEX Fund
FEP
$513M
| $378K | ﹤0.01% |
10,051
+490
| +5% | +$17.6K |
|
1503
iShares Core MSCI International Developed Markets ETF
IDEV
$31B
| $378K | ﹤0.01% |
6,494
| – | – |
|
1504
Celcuity
CELC
$4.03B
| $377K | ﹤0.01% |
35,417
-8,000
| -18% | -$105K |
|
|
SNT
1505
Senstar Technologies
SNT
$41.1M
| $377K | ﹤0.01% |
100,642
| – | – |
|
1506
Regal Rexnord
RRX
$14.2B
| $376K | ﹤0.01% |
4,393
+316
| +8% | +$25.1K |
|
1507
Match Group
MTCH
$8.84B
| $375K | ﹤0.01% |
4,572
+639
| +16% | +$46.5K |
|
1508
Banco Bradesco
BBD
$38.1B
| $374K | ﹤0.01% |
55,652
+5,665
| +11% | +$35.5K |
|
1509
Amplify BlueStar Israel Technology ETF
ITEQ
$114M
| $374K | ﹤0.01% |
+8,651
| New | +$361K |
|
1510
Ingevity
NGVT
$2.55B
| $373K | ﹤0.01% |
4,265
-330
| -7% | -$28.9K |
|
1511
Dave & Buster's
PLAY
$343M
| $373K | ﹤0.01% |
9,277
-2,653
| -22% | -$106K |
|
1512
Cinemark Holdings
CNK
$3.82B
| $372K | ﹤0.01% |
11,006
-60
| -0.5% | -$2.12K |
|
1513
Integra LifeSciences
IART
$1.54B
| $372K | ﹤0.01% |
6,391
+524
| +9% | +$31.2K |
|
1514
Vanguard Industrials ETF
VIS
$8.23B
| $372K | ﹤0.01% |
2,416
+94
| +4% | +$14.1K |
|
|
FMN
1515
Federated Hermes Premier Municipal Income Fund
FMN
$86.9M
| $371K | ﹤0.01% |
26,332
-49,672
| -65% | -$700K |
|
1516
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.74B
| $370K | ﹤0.01% |
14,390
| – | – |
|
1517
Haemonetics
HAE
$3.58B
| $370K | ﹤0.01% |
3,213
-58
| -2% | -$7.02K |
|
1518
NVR
NVR
$17.2B
| $370K | ﹤0.01% |
97
+8
| +9% | +$29.6K |
|
1519
ACI Worldwide
ACIW
$5.72B
| $369K | ﹤0.01% |
9,717
-104
| -1% | -$3.54K |
|
1520
Commercial Metals
CMC
$7.63B
| $368K | ﹤0.01% |
16,558
+35
| +0.2% | +$709 |
|
|
ESPR
1521
DELISTED
Esperion Therapeutics
ESPR
| $368K | ﹤0.01% |
6,159
+3,129
| +103% | +$141K |
|
|
SRCI
1522
DELISTED
SRC Energy Inc
SRCI
| $367K | ﹤0.01% |
89,126
+10,716
| +14% | +$40.7K |
|
1523
Nomura Holdings
NMR
$28.7B
| $366K | ﹤0.01% |
70,781
-1,101
| -2% | -$5.31K |
|
1524
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $365K | ﹤0.01% |
18,177
-285
| -2% | -$5.52K |
|
|
WMGI
1525
DELISTED
Wright Medical Group Inc
WMGI
| $365K | ﹤0.01% |
11,976
-18,987
| -61% | -$497K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.